Rijuran Cosmetic, a premium derma-cosmetic brand from PharmaResearch, is set to expand its presence in the Southeast Asian market by launching in Sephora Singapore.
Starting September 2, Rijuran Cosmetic will be featured as a participating brand in the 'Olive Young K-Beauty Edit,' which selects competitive K-beauty brands for dedicated displays in Sephora stores.
The brand is recognized for its product competitiveness and global growth potential, based on PharmaResearch's patented ingredient, 'DOT® c-PDRN.'
At Sephora Singapore, Rijuran will showcase a total of 10 products, including its flagship items, the 'Rijuran Dual Effect Ampoule' and 'Rijuran Turnover Ampoule.' The 'Rijuran Skin Protection Mask,' which won the '2025 Olive Young Slow Aging Awards,' along with products from the 'Rijuran Pore Tightening' line, including ampoules, toner pads, gel masks, and cleansing balms, will also be available.
With this launch, Rijuran Cosmetic plans to enhance its local marketing efforts through October. The brand will conduct outdoor advertising linked to its Sephora entry and participate in a pop-up store at the Ion Orchard and VivoCity Sephora locations from September 2 to 29.
Additionally, from October 8 to 14, Rijuran will host a curation pop-up store at Ion Orchard, featuring product displays and skin diagnosis leaflets, along with a personalized product recommendation program for Sephora membership holders.
In June, Rijuran's Dual Effect Ampoule ranked second in the ampoule and serum category on the Southeast Asian e-commerce platform Shopee, confirming its market viability. The company aims to strengthen its position in Singapore's premium derma-cosmetic market by expanding offline sales alongside its online presence through the Sephora launch.
A PharmaResearch representative stated, 'The entry into Sephora Singapore will serve as an opportunity to expand our offline consumer touchpoints. We will strengthen collaborations with global distribution partners and expand our overseas business with products and marketing strategies tailored to market demands.'
Meanwhile, the company is also working on expanding its pipeline utilizing c-PDRN, recently introducing 'Gyner,' its first product for the gynecology market, following its scalp booster.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.